High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$2.0M
$2,037,994
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
LGND
M
LIGAND PHARMACEUTICALS INC
Reardon Andrew
• Officer • CLO & Secretary
Other
2026-04-01
$261,350
|
||||||
| LGND |
LIGAND PHARMACEUTICALS INC
|
Officer • CLO & Secretary
Other
|
2026-04-01 | $261,350 | M | Form 4 |
|
LGND
S
LIGAND PHARMACEUTICALS INC
Reardon Andrew
• Officer • CLO & Secretary
10b5-1 Sell
2026-04-01
$91,471
|
||||||
| LGND |
LIGAND PHARMACEUTICALS INC
|
Officer • CLO & Secretary
10b5-1 Sell
|
2026-04-01 | $91,471 | S | Form 4 |
|
LGND
S
LIGAND PHARMACEUTICALS INC
Reardon Andrew
• Officer • CLO & Secretary
10b5-1 Sell
2026-04-01
$260,038
|
||||||
| LGND |
LIGAND PHARMACEUTICALS INC
|
Officer • CLO & Secretary
10b5-1 Sell
|
2026-04-01 | $260,038 | S | Form 4 |
|
LGND
S
LIGAND PHARMACEUTICALS INC
Reardon Andrew
• Officer • CLO & Secretary
10b5-1 Sell
2026-04-01
$248,767
|
||||||
| LGND |
LIGAND PHARMACEUTICALS INC
|
Officer • CLO & Secretary
10b5-1 Sell
|
2026-04-01 | $248,767 | S | Form 4 |
|
LGND
S
LIGAND PHARMACEUTICALS INC
Reardon Andrew
• Officer • CLO & Secretary
10b5-1 Sell
2026-04-01
$141,328
|
||||||
| LGND |
LIGAND PHARMACEUTICALS INC
|
Officer • CLO & Secretary
10b5-1 Sell
|
2026-04-01 | $141,328 | S | Form 4 |
|
LGND
S
LIGAND PHARMACEUTICALS INC
Reardon Andrew
• Officer • CLO & Secretary
10b5-1 Sell
2026-04-01
$195,703
|
||||||
| LGND |
LIGAND PHARMACEUTICALS INC
|
Officer • CLO & Secretary
10b5-1 Sell
|
2026-04-01 | $195,703 | S | Form 4 |
|
LGND
S
LIGAND PHARMACEUTICALS INC
Reardon Andrew
• Officer • CLO & Secretary
10b5-1 Sell
2026-04-01
$68,917
|
||||||
| LGND |
LIGAND PHARMACEUTICALS INC
|
Officer • CLO & Secretary
10b5-1 Sell
|
2026-04-01 | $68,917 | S | Form 4 |
|
LGND
S
LIGAND PHARMACEUTICALS INC
Reardon Andrew
• Officer • CLO & Secretary
10b5-1 Sell
2026-03-04
$94,382
|
||||||
| LGND |
LIGAND PHARMACEUTICALS INC
|
Officer • CLO & Secretary
10b5-1 Sell
|
2026-03-04 | $94,382 | S | Form 4 |
|
LGND
S
LIGAND PHARMACEUTICALS INC
Reardon Andrew
• Officer • CLO & Secretary
10b5-1 Sell
2026-03-04
$70,165
|
||||||
| LGND |
LIGAND PHARMACEUTICALS INC
|
Officer • CLO & Secretary
10b5-1 Sell
|
2026-03-04 | $70,165 | S | Form 4 |
|
LGND
M
LIGAND PHARMACEUTICALS INC
Reardon Andrew
• Officer • CLO & Secretary
Other
2026-03-04
$261,350
|
||||||
| LGND |
LIGAND PHARMACEUTICALS INC
|
Officer • CLO & Secretary
Other
|
2026-03-04 | $261,350 | M | Form 4 |
|
LGND
S
LIGAND PHARMACEUTICALS INC
Reardon Andrew
• Officer • CLO & Secretary
10b5-1 Sell
2026-03-04
$300,939
|
||||||
| LGND |
LIGAND PHARMACEUTICALS INC
|
Officer • CLO & Secretary
10b5-1 Sell
|
2026-03-04 | $300,939 | S | Form 4 |
|
LGND
S
LIGAND PHARMACEUTICALS INC
Reardon Andrew
• Officer • CLO & Secretary
10b5-1 Sell
2026-03-04
$238,532
|
||||||
| LGND |
LIGAND PHARMACEUTICALS INC
|
Officer • CLO & Secretary
10b5-1 Sell
|
2026-03-04 | $238,532 | S | Form 4 |
|
LGND
S
LIGAND PHARMACEUTICALS INC
Reardon Andrew
• Officer • CLO & Secretary
10b5-1 Sell
2026-03-04
$126,689
|
||||||
| LGND |
LIGAND PHARMACEUTICALS INC
|
Officer • CLO & Secretary
10b5-1 Sell
|
2026-03-04 | $126,689 | S | Form 4 |
|
LGND
S
LIGAND PHARMACEUTICALS INC
Reardon Andrew
• Officer • CLO & Secretary
10b5-1 Sell
2026-03-04
$19,770
|
||||||
| LGND |
LIGAND PHARMACEUTICALS INC
|
Officer • CLO & Secretary
10b5-1 Sell
|
2026-03-04 | $19,770 | S | Form 4 |
|
LGND
S
LIGAND PHARMACEUTICALS INC
Reardon Andrew
• Officer • CLO & Secretary
10b5-1 Sell
2026-03-04
$19,900
|
||||||
| LGND |
LIGAND PHARMACEUTICALS INC
|
Officer • CLO & Secretary
10b5-1 Sell
|
2026-03-04 | $19,900 | S | Form 4 |
|
LGND
S
LIGAND PHARMACEUTICALS INC
Reardon Andrew
• Officer • CLO & Secretary
10b5-1 Sell
2026-03-04
$41,391
|
||||||
| LGND |
LIGAND PHARMACEUTICALS INC
|
Officer • CLO & Secretary
10b5-1 Sell
|
2026-03-04 | $41,391 | S | Form 4 |
|
LGND
S
LIGAND PHARMACEUTICALS INC
Reardon Andrew
• Officer • CLO & Secretary
10b5-1 Sell
2026-03-04
$18,658
|
||||||
| LGND |
LIGAND PHARMACEUTICALS INC
|
Officer • CLO & Secretary
10b5-1 Sell
|
2026-03-04 | $18,658 | S | Form 4 |
|
LGND
S
LIGAND PHARMACEUTICALS INC
Reardon Andrew
• Officer • CLO & Secretary
10b5-1 Sell
2026-03-04
$60,510
|
||||||
| LGND |
LIGAND PHARMACEUTICALS INC
|
Officer • CLO & Secretary
10b5-1 Sell
|
2026-03-04 | $60,510 | S | Form 4 |
|
LGND
S
LIGAND PHARMACEUTICALS INC
Reardon Andrew
• Officer • CLO & Secretary
10b5-1 Sell
2026-03-04
$40,834
|
||||||
| LGND |
LIGAND PHARMACEUTICALS INC
|
Officer • CLO & Secretary
10b5-1 Sell
|
2026-03-04 | $40,834 | S | Form 4 |